Effect of the temperature on a hydrate diclofenac salt

International Journal of Pharmaceutics

Volumn 181, Issue 1, 1999, Pages 95-106

  Fini, A ^a   Fazio, G ^a   Rabasco, A M ^b   Fernandez Hervas M J ^b   Holgado, M A ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Depto Farmacia Y Tecn F   (Spain)

Author keywords

Anhydrous forms; De hydration; Di hydrate form; Diclofenac N (2 hydroxyethyl) pyrrolidine; Fractal dimension; Phase transition; Reactive dimension; Thermal analysis

Indexed keywords

DICLOFENAC;

ARTICLE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; CRYSTALLIZATION; DEHYDRATION; NONHUMAN; PARTICLE SIZE; PHASE TRANSITION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TEMPERATURE; THERMAL ANALYSIS; THERMOGRAPHY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CALORIMETRY, DIFFERENTIAL SCANNING; CRYSTALLIZATION; DICLOFENAC; DRUG STABILITY; HEATING; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSCOPY, ELECTRON, SCANNING; SURFACE PROPERTIES; TEMPERATURE; TIME FACTORS; WATER;

EID: 0032952997     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00010-1     Document Type: Article

References (13)

1. Caraballo I., Alvarez-Fuentes J., Melgoza L., Millán M., Holgado M.A., Rabasco A.M., Fernández-Arévalo M. Validation study of the conductometrical analysis. Application to the drug release studies from controlled release systems. J. Pharm. Biom. Anal. 18:1998;281-285.
2. Castellari C., Sabatino P. Anti-inflammatory drugs: 1-(2-hydroxyethyl) pyrrolidinium salt of diclofenac. Acta Cryst. C50:1994;1723-1726.
3. Fernández-Hervás M.J., Holgado M.A., Rabasco A.M., Fini A. Use of fractal geometry on the characterization of particles morphology. Application to the diclofenac hydroxyethylpyrrolidine. Int. J. Pharm. 108:1994;187-194.
4. Fernández-Hervás M.J., Holgado M.A., Rabasco A.M., Fazio G., Fini A. Fractal and reactive dimension of a diclofenac salt: effect of the experimental conditions. Int. J. Pharm. 136:1996;101-106.
5. Fini A., Fazio G., Orienti I., Zecchi V., Rapaport I. Chemical properties-dissolution relationship: IV. Behavior in solution of the diclofenac/N-(2-hydroxyethyl)pyrrolidine salt (DHEP). Pharm. Acta Helv. 66:1991;201-203.
6. Fini A., Fazio G., Fernández-Hervás M.J., Holgado M.A., Rabasco A.M. Influence of crystallization solvent and dissolution behaviour for a diclofenac salt. Int. J. Pharm. 121:1995;19-26.
7. Fini A., Sánchez-Soto P.J., Fernández-Hervás M.J., Holgado M.A. Thermal analysis of the de-hydrated form of a diclofenac salt. Int. J. Pharm. 165:1998;79-85.
8. Fini, A., Fazio, G., Alvarez-Fuentes, J., Fernández-Hervás, M.J., Holgado, M.A., 1999. De-hydration and re-hydration of a hydrate diclofenac salt at room temperature, Int. J. Pharm., in press.
9. Ford J.L., Timmins P. Pharmaceutical Thermal Analysis. 1989;Ellis Horwood, Chichester, UK.
10. Holgado M.A., Fernández-Hervás M.J., Rabasco A.M., Fini A. Characterization study of a diclofenac salt by means of SEM and fractal analysis. Int. J. Pharm. 120:1995;157-167.
11. Ledwidge M.T., Draper S.M., Wilcock D.J., Corrigan O.I. Physico-chemical characterization of diclofenac/N-(2-hydroxyethyl) pyrrolidine: anhydrate and dihydrate crystalline forms. J. Pharm. Sci. 85:1996;16-21.
12. Ledwidge M.T., Corrigan O.I. Effects of environmental factors on the dehydration of diclofenac HEP dihydrate and theophylline monohydrate. Int. J. Pharm. 147:1997;41-49.
13. Ziggiotti A. Diclofenac-(hydroxyalkyl) heterocycle salts, their preparation, their pharmaceutical formulation, Eur. Pat. Appl. EP 271, 709, Chem. Abs. 110: 141562m. 1988.